MARKET ACCESS

DOWNLOAD AGENDA

 

Access, Tuesday 19 March 2019

08:45

Organiser’s welcome Remarks

Joe Zhou
08:50

Chair’s opening Remarks

Joe Zhou, Chief Executive Officer, Genor BioPharma, Walvax Group

Opening Keynote Plenary

David Lane
09:00

Going global and keeping it local: Is biotech innovation sustainable in Asia?

In this keynote presentation, Sir David Lane, one of the key scientists credited on the discovery of cancer gene p53, a gene which mutation cause near 50% of all human cancer, will share his view on how biomedical sciences have developed in Singapore, Japan and the remaining APAC region, and prospects for Asian biotech and pharma industry.
Byung-Geon Rhee
09:20

Looking east: Integrating Asia into the global era of innovative medicine

Panel discussion
09:40

Pharma Trends: Women health as the next focus

By 2023, it is estimated that the women’s health market will be worth $37.4 billion. But despite this impressive growth, across the world there are still significant unmet needs in the space. In this panel discussion, we will explore the significant opportunities in the women’s health market, from drug discovery and development to effective clinical trials and ensuring access to treatment, including both strategy development and technology advances.
Nilesh Wadhwa
10:10

Driving innovation forward: The Johnson & Johnson perspective

Fostering innovation is a big challenge, so what’s the recipe for success? In this session, learn about how Johnson & Johnson Innovation is helping to accelerate life sciences innovation and how its Asia Pacific team is creating new opportunities for emerging biotech and pharma businesses. Nilesh will share insights into Johnson & Johnson’s unique model for addressing the major challenges in local innovation ecosystems, and how new collaborations are helping transform the trajectory of human health.
10:30

Exhibition visit & networking refreshments

PATIENT ACCESS

Access
11:15

Chair's opening remarks

Edmund Lim
Access
11:20

Stakeholder mapping, acquisition & activation strategies

Panel discussion
Access
11:40

Collaborative efforts in building the common ground for better accessibility and treatment

  • Key actions to bridge the gaps between stakeholders to provide for population in need
  • Models in helping advocacy group to coordinate for better access to treatment
  • Building the common ground in promoting better collaboration between advocacy groups, government, pharma and other stakeholders
12:40

Exhibition Visit & Networking Lunch

EVIDENCE BASED APPROACH

Access
14:10

Chair’s opening remarks

Anand Jha
Access
14:20

Making a value-outcome-based reimbursement model possible: How do we get there?

Access
14:40

Making a value-outcome-based reimbursement model possible: How do we get there?

Panel discussion
Access
14:50

RWE as the basis of value-based reimbursement: Applications in APAC’s pharma industry

  • Overview of data-driven reimbursement process in APAC
  • Overcoming barriers to increase use of real world data
  • Improving quality of real world data
  • Standardising access and quality of RWE analytics
  • Working with payors and regulators on possible value based reimbursement model for innovative drugs and beyond
15:40

Exhibition Visit & Networking Refreshments

VALUE & AFFORDABILITY

Susanne Weissbaecker
Access
16:40

Providing affordable access to patients in developing countries and underserved communities

Shailendra Bajpai
Access
17:00

Cost management & innovative pricing strategies in high value disease management (topic to be confirmed)

Dr Sushant Sahastrabuddhe
Access
17:20

Technology transfer and Product Development Partnerships (PDPs) in making vaccines affordable

17:40

Networking Cocktail & End of Conference Day 1

last published: 18/Mar/19 14:05

 

 

 

DOWNLOAD PROSPECTUS

 

 

For speaking, sponsorship and exhibition opportunities contact jonathan.mottram@terrapinn.com
Tel: +65 6322 2738